Literature DB >> 2471637

Two out of the three kinds of subunits of inter-alpha-trypsin inhibitor are structurally related.

W Gebhard1, T Schreitmüller, K Hochstrasser, E Wachter.   

Abstract

Inter-alpha-trypsin inhibitor is a 240-kDa plasma-protein complex of three different types of glycoproteins. Their stoichiometric relation in the complex is not yet known. One subunit results from proteolytic processing of a precursor protein composed of alpha 1-microglobulin and a double-headed Kunitz-type proteinase inhibitor protein. From this, only the inhibitor protein becomes part of the inter-alpha-trypsin inhibitor complex. Another subunit whose function is not yet understood is structurally unrelated to the first one as well as to other proteins of various data collections. Now we have obtained a cDNA clone coding for 837 amino acid residues of a precursor protein of the third subunit. Its primary structure is 40% identical to that of the completely known second-subunit precursor. Peptide sequences obtained from isolated inter-alpha-trypsin inhibitor represent a distinct part of only about two thirds of the predicted polypeptide precursor, suggesting that its maturation is very similar to that of the second subunit. Therefore, we conclude that the deduced primary structure covers about 98% of the mature third subunit.

Mesh:

Substances:

Year:  1989        PMID: 2471637     DOI: 10.1111/j.1432-1033.1989.tb14762.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  More von Willebrand factor type A domains? Sequence similarities with malaria thrombospondin-related anonymous protein, dihydropyridine-sensitive calcium channel and inter-alpha-trypsin inhibitor.

Authors:  P Bork; K Rohde
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

2.  Inter-alpha-trypsin inhibitor polymorphism. An improved phenotyping procedure and two new alleles.

Authors:  A Harada; K Umetsu; T Suzuki
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

3.  Distribution and localization of inter-alpha-trypsin inhibitor and its active component acid-stable proteinase inhibitor: comparative immunohistochemical study.

Authors:  E Yoshida; H Sumi; H Tsushima; M Maruyama; H Mihara
Journal:  Inflammation       Date:  1991-02       Impact factor: 4.092

4.  Intracellular coupling of bikunin and the heavy chain of rat pre-alpha-inhibitor in COS-1 cells.

Authors:  A M Blom; M Thuveson; E Fries
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

5.  Human inter-alpha-inhibitor family in inflammation: simultaneous synthesis of positive and negative acute-phase proteins.

Authors:  M Daveau; P Rouet; M Scotte; L Faye; M Hiron; J P Lebreton; J P Salier
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

6.  Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respiratory tract.

Authors:  K Hochstrasser; W Gebhard; G Albrecht; G Rasp; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

7.  The three heavy-chain precursors for the inter-alpha-inhibitor family in mouse: new members of the multicopper oxidase protein group with differential transcription in liver and brain.

Authors:  P Chan; J L Risler; G Raguenez; J P Salier
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

8.  Glycosylation pattern of human inter-alpha-inhibitor heavy chains.

Authors:  C Flahaut; C Capon; M Balduyck; G Ricart; P Sautiere; J Mizon
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

9.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

10.  Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis.

Authors:  Alexander Hamm; Juergen Veeck; Nuran Bektas; Peter J Wild; Arndt Hartmann; Uwe Heindrichs; Glen Kristiansen; Tamra Werbowetski-Ogilvie; Rolando Del Maestro; Ruth Knuechel; Edgar Dahl
Journal:  BMC Cancer       Date:  2008-01-28       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.